Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma

Aim: This study was designed to evaluate the clinical application of serum total sialic acid (ISA) in the diagnosis of cholangiocarcinoma (CCA). Methods: Serum TSA was determined by periodateresorcinol microassay in 69 patients with CCA, 59 patients with hepatocellular carcinoma (HCC), 37 patients w...

全面介紹

Saved in:
書目詳細資料
Main Authors: Kongtawelert P., Tangkijvanich P., Ong-Chai S., Poovorawan Y.
格式: Article
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-0142183162&partnerID=40&md5=ece5495d72380d50e7d1d92fc79e6dda
http://www.ncbi.nlm.nih.gov/pubmed/14562373
http://cmuir.cmu.ac.th/handle/6653943832/2838
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University
語言: English
實物特徵
總結:Aim: This study was designed to evaluate the clinical application of serum total sialic acid (ISA) in the diagnosis of cholangiocarcinoma (CCA). Methods: Serum TSA was determined by periodateresorcinol microassay in 69 patients with CCA, 59 patients with hepatocellular carcinoma (HCC), 37 patients with cirrhosis, 61 patients with chronic hepatitis and 50 healthy blood donors. Results: The mean serum TSA concentration in CCA (2.41±0.70 mmol/L) was significantly higher than those of HCC, cirrhosis, chronic hepatitis and healthy blood donors (1.41±0.37 mmol/L, 1.13±0.31 mmol/L, 1.16±0.26 mmol/L, and 1.10±0.14 mmol/L, respectively; p<0.001). Based on ROC curve analysis, a cut-off point of 1.75 mmol/L discriminated between CCA and HCC with a sensitivity, specificity and accuracy of 82.6 %, 83.1 %, and 82.8 %, respectively. Conclusion: Based on our results, serum TSA would be a useful marker for the differential diagnosis of CCA from HCC.